rood blauwe elepsis logo Belegger.nl

uniQure Terug naar discussie overzicht

Wat is de waarde van uniQure?

7.835 Posts
Pagina: «« 1 ... 274 275 276 277 278 ... 392 »» | Laatste | Omlaag ↓
  1. [verwijderd] 15 maart 2017 16:28
    quote:

    Dogder schreef op 15 maart 2017 16:24:

    [...]

    Wat betekend dit flosz?
    Shelf Offering
    Share
    What it is:

    A shelf offering is a sale of stock by a company over time.
    How it works (Example):

    Let's say Company XYZ is a public company and would like to sell shares in order to raise money to build a new factory. The company already has some Series A common stock outstanding; this new offering would be of Series B common stock that carries a different dividend. Company XYZ wants to sell 1 million shares of the stock, but it doesn't need the money all at once, so it files a shelf offering with the SEC under Rule 415 of Regulation C of the Securities Act of 1933.

    Company XYZ hires an investment bank to underwrite the offering, register it with the SEC and handle the sale. The company receives the proceeds from the sale of the shares.

    Generally, a company can register a shelf offering up to three years in advance, meaning that it has that long to sell the shares. The company files a Form S-3, F-3, or F-6 to do this (the form depends on the type of security and the nature of the issuer). The issuer still has to file the quarterly, annual and other disclosures with the SEC even if it hasn't actually issued any securities under the shelf. If the three-year window is getting close to closing and the company hasn't sold all of the securities in the shelf registration, it can often file replacement registration statements to extend the offering.

    Shelf offerings can be delayed offerings or continuous offerings. In a continuous offering, the company is agreeing to make shares available for sale immediately (though it might not actually sell any immediately, and that is the company's choice); in a delayed offering, the company does not intend to make any shares available for sale until later in the three-year window. The information contained in the shelf offering statement varies depending on whether the offering is delayed or continuous and whether the issuer is already public. Regardless, most of the time the prospectus describes the type of security offered, a summary of the issuer's business, the use of proceeds, and the plan of distribution. Sometimes the issuer will provide a prospectus supplement with more detail.

    When the company actually issues shares registered under the shelf offering, we say the company is doing a "takedown."
  2. forum rang 10 DeZwarteRidder 15 maart 2017 16:35
    quote:

    Dogder schreef op 15 maart 2017 16:34:

    Zou je het kunnen uitleggen?
    Dit is de voorbereiding voor het uitgeven van nieuwe aandelen en/of obligaties en/of warrants, etc.
  3. [verwijderd] 15 maart 2017 17:08
    Form S-3 registration: In March 2015, the Company filed a “shelf registration statement” on Form F-3 with the Securities and Exchange Commission. Now that the Company reports as a domestic issuer, the F-3 registration statement is no longer



    effective, and therefore the Company today will file a new shelf registration statement on Form S-3. This will provide the Company with important financial flexibility for advancing its programs in the future. The Company has no immediate plans for any financing transaction.
  4. forum rang 10 DeZwarteRidder 15 maart 2017 17:18
    quote:

    Dogder schreef op 15 maart 2017 17:10:

    BTW geld is op in begin 2019
    Grapjas...!!
    Dit jaar vliegt er weer ca 100 miljoen de deur uit en ze moeten ca 20 miljoen aan leningen aflossen.

    Dus ik verwacht een emissie tegen het eind van dit jaar; het zou immers heel dom zijn om te wachten tot het geld echt op is.
  5. [verwijderd] 15 maart 2017 17:37
    Ik verwacht een samenwerkingsverband
    voor een programma dit jaar of begin volgend jaar. Als je luisterd naar de call van vorige week en als ik kijk naar de mensen die ze aannemen.
  6. [verwijderd] 16 maart 2017 15:41
    die 250kk bestaat dus al vanaf 2015 ..

    On April 3, 2015, uniQure N.V. (the “Registrant”) filed a registration statement, Registration No. 333-202456 (the “Registration Statement”), relating to the registration of sales, from time to time pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), of up to an aggregate of $250,000,000 of the Registrant’s debt securities, warrants, rights, purchase contracts, units and ordinary shares. On April 13, 2015, the Registrant filed a prospectus supplement to the Registration Statement pursuant to Rule 424(b)(5) by which the Registrant sold an aggregate amount of $88,500,000 in ordinary shares.

    As of January 1, 2017, the Registrant no longer qualified as a foreign private issuer under the rules and regulations of the U.S. Securities and Exchange Commission. As the Registrant is no longer a foreign private issuer, it is no longer eligible to offer securities via a Form F-3 registration statement. Therefore, this Post-Effective Amendment No. 1 is being filed in order to deregister the remaining aggregate amount of $161,500,000 debt securities, warrants, rights, purchase contracts, units and ordinary shares registered for sale under the Registration Statement.
  7. Prof. Dollar 21 maart 2017 21:33
    Zojuist live de webcast beluisterd van uniQure tijdens Oppenheimer 27th Annual Healthcare Conference. Inhoudelijk niks nieuws, maar Matt Kapusta heeft goed gepresenteerd. In juli en december kan een update Hem. B data worden verwacht. En tussentijds wat data over Huntington.

    www.veracast.com/webcasts/opco/health...
  8. QLVT 21 maart 2017 22:54
    De vraag is word het nog iets met UNIQURE ,als er een goede producten komen word het een top aandeel boven proporties,maar daar lijkt het nu niet op .Onze meeste trouwe aanhangers zijn al weg.....
  9. Tex Mex 21 maart 2017 23:45
    quote:

    cqtvld schreef op 21 maart 2017 22:54:

    Onze meeste trouwe aanhangers zijn al weg.....
    Hart onder de riem: ik zit er nog (onveranderd) vol in.
  10. T. Montana 23 maart 2017 17:33
    En ik ben helemaal de weg kwijt sinds de verdwijning van rationeel :) Ik overzie rustig de puinhopen terwijl ik een goed glas inschenk. Komt allemaal wel. Eerlijk gezegd, niet zo slecht dat alle hype er is uitgelopen.
7.835 Posts
Pagina: «« 1 ... 274 275 276 277 278 ... 392 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.012
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.547
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.589
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.732
Aedifica 3 903
Aegon 3.258 322.688
AFC Ajax 538 7.087
Affimed NV 2 6.295
ageas 5.844 109.887
Agfa-Gevaert 14 2.049
Ahold 3.538 74.331
Air France - KLM 1.025 35.024
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.701
Allfunds Group 4 1.469
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.821
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.941
AMG 971 133.210
AMS 3 73
Amsterdam Commodities 305 6.687
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.975
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.767
Arcelor Mittal 2.033 320.667
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.296
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.089
ASML 1.766 106.524
ASR Nederland 21 4.452
ATAI Life Sciences 1 7
Atenor Group 1 485
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.647
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392